PAR Drugs and Chemicals Limited

PAR Drugs held its 27th Annual General Meeting on 26-Sep-2026 to present FY26 results and conduct shareholder voting. Company reported FY26 total income of ₹107.66 crore and PAT of ₹13.11 crore, maint